Sirtris’ Red Wine Chemical to Take Back Seat to “Potent” Diabetes...

Posted in Diabetes drugs  at Mon, 01 Dec 2008 16:03:39 -0800

Now the company, a wholly-owned subsidiary of British drug giant GlaxoSmithKline (NYSE:GSK), plans to increase its focus on developing a more potent molecule to treat diabetes, according to CEO Christoph Westphal. ...

Original article: Sirtris’ Red Wine Chemical to Take Back Seat to “Potent” Diabetes... by at diabetes drugs - Google Blog Search

Tags: